1185 related articles for article (PubMed ID: 17536875)
1. Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.
Peters PJ; Thigpen MC; Parise ME; Newman RD
Drug Saf; 2007; 30(6):481-501. PubMed ID: 17536875
[TBL] [Abstract][Full Text] [Related]
2. Mefloquine for preventing malaria in pregnant women.
González R; Pons-Duran C; Piqueras M; Aponte JJ; Ter Kuile FO; Menéndez C
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011444. PubMed ID: 29561063
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi.
Filler SJ; Kazembe P; Thigpen M; Macheso A; Parise ME; Newman RD; Steketee RW; Hamel M
J Infect Dis; 2006 Aug; 194(3):286-93. PubMed ID: 16826475
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Azithromycin-Chloroquine versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment of Plasmodium falciparum Malaria Infection in Pregnant Women in Africa: An Open-Label, Randomized Trial.
Kimani J; Phiri K; Kamiza S; Duparc S; Ayoub A; Rojo R; Robbins J; Orrico R; Vandenbroucke P
PLoS One; 2016; 11(6):e0157045. PubMed ID: 27326859
[TBL] [Abstract][Full Text] [Related]
5. Intermittent preventive therapy for malaria in pregnancy: is sulfadoxine-pyrimethamine the right drug?
Parikh S; Rosenthal PJ
Clin Pharmacol Ther; 2010 Feb; 87(2):160-2. PubMed ID: 20107451
[TBL] [Abstract][Full Text] [Related]
6. Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa.
Eisele TP; Larsen DA; Anglewicz PA; Keating J; Yukich J; Bennett A; Hutchinson P; Steketee RW
Lancet Infect Dis; 2012 Dec; 12(12):942-9. PubMed ID: 22995852
[TBL] [Abstract][Full Text] [Related]
7. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.
Esu E; Berens-Riha N; Pritsch M; Nwachuku N; Loescher T; Meremikwu M
Malar J; 2018 Jul; 17(1):251. PubMed ID: 29976228
[TBL] [Abstract][Full Text] [Related]
8. Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy.
Hommerich L; von Oertzen C; Bedu-Addo G; Holmberg V; Acquah PA; Eggelte TA; Bienzle U; Mockenhaupt FP
Malar J; 2007 Nov; 6():144. PubMed ID: 17996048
[TBL] [Abstract][Full Text] [Related]
9. Mefloquine for preventing malaria in pregnant women.
González R; Pons-Duran C; Piqueras M; Aponte JJ; Ter Kuile FO; Menéndez C
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011444. PubMed ID: 30480761
[TBL] [Abstract][Full Text] [Related]
10. Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trial.
Jagannathan P; Kakuru A; Okiring J; Muhindo MK; Natureeba P; Nakalembe M; Opira B; Olwoch P; Nankya F; Ssewanyana I; Tetteh K; Drakeley C; Beeson J; Reiling L; Clark TD; Rodriguez-Barraquer I; Greenhouse B; Wallender E; Aweeka F; Prahl M; Charlebois ED; Feeney ME; Havlir DV; Kamya MR; Dorsey G
PLoS Med; 2018 Jul; 15(7):e1002606. PubMed ID: 30016328
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection.
Parise ME; Ayisi JG; Nahlen BL; Schultz LJ; Roberts JM; Misore A; Muga R; Oloo AJ; Steketee RW
Am J Trop Med Hyg; 1998 Nov; 59(5):813-22. PubMed ID: 9840604
[TBL] [Abstract][Full Text] [Related]
12. Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis.
van Eijk AM; Larsen DA; Kayentao K; Koshy G; Slaughter DEC; Roper C; Okell LC; Desai M; Gutman J; Khairallah C; Rogerson SJ; Hopkins Sibley C; Meshnick SR; Taylor SM; Ter Kuile FO
Lancet Infect Dis; 2019 May; 19(5):546-556. PubMed ID: 30922818
[TBL] [Abstract][Full Text] [Related]
13. Impact of Sulfadoxine-Pyrimethamine Resistance on Effectiveness of Intermittent Preventive Therapy for Malaria in Pregnancy at Clearing Infections and Preventing Low Birth Weight.
Desai M; Gutman J; Taylor SM; Wiegand RE; Khairallah C; Kayentao K; Ouma P; Coulibaly SO; Kalilani L; Mace KE; Arinaitwe E; Mathanga DP; Doumbo O; Otieno K; Edgar D; Chaluluka E; Kamuliwo M; Ades V; Skarbinski J; Shi YP; Magnussen P; Meshnick S; Ter Kuile FO
Clin Infect Dis; 2016 Feb; 62(3):323-333. PubMed ID: 26486699
[TBL] [Abstract][Full Text] [Related]
14. Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women.
Hamer DH; Mwanakasale V; Macleod WB; Chalwe V; Mukwamataba D; Champo D; Mwananyanda L; Chilengi R; Mubikayi L; Mulele CK; Mulenga M; Thea DM; Gill CJ
J Infect Dis; 2007 Dec; 196(11):1585-94. PubMed ID: 18008241
[TBL] [Abstract][Full Text] [Related]
15. Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study.
Taylor SM; Antonia AL; Chaluluka E; Mwapasa V; Feng G; Molyneux ME; ter Kuile FO; Meshnick SR; Rogerson SJ
Clin Infect Dis; 2012 Jul; 55(1):42-50. PubMed ID: 22441649
[TBL] [Abstract][Full Text] [Related]
16. Decrease of microscopic Plasmodium falciparum infection prevalence during pregnancy following IPTp-SP implementation in urban cities of Gabon.
Bouyou-Akotet MK; Mawili-Mboumba DP; Kendjo E; Moutandou Chiesa S; Tshibola Mbuyi ML; Tsoumbou-Bakana G; Zong J; Ambounda N; Kombila M
Trans R Soc Trop Med Hyg; 2016 Jun; 110(6):333-42. PubMed ID: 27268713
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacovigilance and impact of intermittent preventive treatment with sulfadoxine-pyrimethamine in pregnant women in Sélingué, Mali].
Maiga AS; Diakite M; Diawara A; Sango HA; Coulibaly CO
Mali Med; 2010; 25(3):41-8. PubMed ID: 21441083
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data.
Fernandes S; Sicuri E; Kayentao K; van Eijk AM; Hill J; Webster J; Were V; Akazili J; Madanitsa M; ter Kuile FO; Hanson K
Lancet Glob Health; 2015 Mar; 3(3):e143-53. PubMed ID: 25701992
[TBL] [Abstract][Full Text] [Related]
19. Intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine and parasite resistance: cross-sectional surveys from antenatal care visit and delivery in rural Ghana.
Mama A; Ahiabor C; Tornyigah B; Frempong NA; Kusi KA; Adu B; Courtin D; Houzé S; Deloron P; Ofori MF; Anang AK; Ariey F; Ndam NT
Malar J; 2022 Mar; 21(1):107. PubMed ID: 35346205
[TBL] [Abstract][Full Text] [Related]
20. Predictors for the uptake of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: further analysis of the data of the 2015-2016 Tanzania demographic and health survey and malaria indicator survey.
Mushi V; Mbotwa CH; Zacharia A; Ambrose T; Moshi FV
Malar J; 2021 Feb; 20(1):75. PubMed ID: 33549094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
